Dobi hopeful on FDA's PMA approval of ComfortScan
This article was originally published in Clinica
Executive Summary
Promising to improve diagnosis for breast cancer, Dobi Medical's novel imaging technology, ComfortScan, was recently launched outside of the US. The company tells Clinica how FDA approval could take the company into profitability within the next two years